BX Lab

Modified Nucleotides

ADP-heptose

Quick view. We supply ADP-heptose as a modified nucleotide for nucleic acid chemistry, enzymology and analytical reference workflows. CAS 322640-23-3. Catalog target purity: Specification on request.

Chemical structure of ADP-heptose
Chemical structure
Catalog numberBX-MN-0090
CAS number322640-23-3
PuritySpecification on request
Pack sizeCustomized to customer requirements

Product profile

Material identity

ADP-heptose is classified as nucleotide or nucleotide analog.

Typical application

ADP-heptose can support enzyme-substrate, in-vitro transcription, polymerase-screening or analytical-reference studies as appropriate to its phosphate state.

Handling focus

For ADP-heptose, confirm the current specification, storage conditions and downstream-method compatibility before routine use.

Names and search terms

Useful catalog search terms

Release documentation

Lot-specific CoA

The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.

Analytical package

Additional HPLC, MS or NMR documentation can be agreed during technical review where available.

Additional application examples

Related products

Frequently asked questions

Can the package size for ADP-heptose be customized?

Yes. Share the initial quantity, expected future scale, delivery timeline and packaging preference for review.

What information should be included in a quote request?

Quote catalog number BX-MN-0090 and CAS 322640-23-3, the intended research workflow, required quantity and any additional HPLC, MS or NMR documentation needed.

Product-family literature

The publications below provide peer-reviewed context for the Modified Nucleotides product family and its named chemistry.

Request a quote